Reuters logo
BRIEF-MabVax Therapeutics Holdings provides corporate overview and business outlook
October 17, 2017 / 11:33 AM / a month ago

BRIEF-MabVax Therapeutics Holdings provides corporate overview and business outlook

Oct 17 (Reuters) - MabVax Therapeutics Holdings Inc

* MabVax Therapeutics Holdings Inc provides corporate overview and business outlook

* MabVax Therapeutics Holdings Inc - expects to report interim data near year-end for phase 1 first-in human clinical trial​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below